tiprankstipranks
Trending News
More News >
Medical Ikkou Group Co., Ltd. (JP:3353)
:3353
Japanese Market
Advertisement

Medical Ikkou Group Co., Ltd. (3353) Ratios

Compare
1 Followers

Medical Ikkou Group Co., Ltd. Ratios

JP:3353's free cash flow for Q3 2024 was ¥0.11. For the 2024 fiscal year, JP:3353's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.54 1.61 1.78 1.73 1.50
Quick Ratio
1.35 1.44 1.61 1.59 1.38
Cash Ratio
0.58 0.74 0.86 0.95 0.77
Solvency Ratio
0.10 0.10 0.11 0.10 0.09
Operating Cash Flow Ratio
0.00 0.41 0.18 0.13 0.20
Short-Term Operating Cash Flow Coverage
0.00 1.16 0.45 0.30 0.45
Net Current Asset Value
¥ -1.55B¥ -1.10B¥ -1.66B¥ -2.59B¥ -4.41B
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.30 0.33 0.39 0.41
Debt-to-Equity Ratio
0.71 0.72 0.76 0.99 1.13
Debt-to-Capital Ratio
0.42 0.42 0.43 0.50 0.53
Long-Term Debt-to-Capital Ratio
0.30 0.30 0.33 0.39 0.42
Financial Leverage Ratio
2.43 2.39 2.28 2.56 2.72
Debt Service Coverage Ratio
0.50 0.51 0.57 0.47 0.42
Interest Coverage Ratio
36.58 28.86 18.41 21.90 19.13
Debt to Market Cap
0.76 1.07 0.92 1.16 0.98
Interest Debt Per Share
2.67K 2.56K 2.44K 3.03K 3.15K
Net Debt to EBITDA
1.22 0.75 1.21 1.38 2.08
Profitability Margins
Gross Profit Margin
11.72%11.41%9.39%10.76%10.14%
EBIT Margin
3.91%4.30%4.03%4.57%4.73%
EBITDA Margin
5.49%6.27%6.51%7.16%7.38%
Operating Profit Margin
3.50%3.91%2.76%3.80%3.25%
Pretax Profit Margin
3.93%4.17%3.88%4.39%4.56%
Net Profit Margin
2.34%2.61%2.24%2.54%2.64%
Continuous Operations Profit Margin
2.37%2.71%2.28%2.59%2.64%
Net Income Per EBT
59.59%62.54%57.82%57.73%57.92%
EBT Per EBIT
112.40%106.63%140.48%115.72%140.23%
Return on Assets (ROA)
3.31%3.28%2.76%2.93%2.92%
Return on Equity (ROE)
8.18%7.85%6.30%7.49%7.96%
Return on Capital Employed (ROCE)
7.50%7.34%4.66%6.17%5.28%
Return on Invested Capital (ROIC)
3.87%4.07%2.40%3.07%2.53%
Return on Tangible Assets
3.41%3.38%2.92%3.11%3.14%
Earnings Yield
9.02%11.85%7.81%8.90%7.03%
Efficiency Ratios
Receivables Turnover
6.47 6.59 6.77 6.87 6.68
Payables Turnover
7.04 7.22 8.93 8.61 8.14
Inventory Turnover
19.28 20.17 25.01 24.70 25.94
Fixed Asset Turnover
4.82 4.38 3.54 3.41 3.12
Asset Turnover
1.41 1.26 1.23 1.15 1.11
Working Capital Turnover Ratio
7.29 6.59 5.68 6.27 7.23
Cash Conversion Cycle
23.47 22.94 27.64 25.50 23.88
Days of Sales Outstanding
56.41 55.41 53.91 53.11 54.68
Days of Inventory Outstanding
18.93 18.10 14.60 14.78 14.07
Days of Payables Outstanding
51.88 50.57 40.87 42.38 44.87
Operating Cycle
75.35 73.51 68.51 67.89 68.75
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 1.14K 348.08 302.19 483.08
Free Cash Flow Per Share
0.00 1.05K 255.58 212.46 353.64
CapEx Per Share
0.00 86.24 92.49 89.73 129.44
Free Cash Flow to Operating Cash Flow
0.00 0.92 0.73 0.70 0.73
Dividend Paid and CapEx Coverage Ratio
0.00 9.02 2.63 2.33 2.81
Capital Expenditure Coverage Ratio
0.00 13.20 3.76 3.37 3.73
Operating Cash Flow Coverage Ratio
0.00 0.45 0.14 0.10 0.15
Operating Cash Flow to Sales Ratio
0.00 0.11 0.04 0.03 0.06
Free Cash Flow Yield
0.00%45.06%9.87%8.33%11.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.45 8.44 12.80 11.24 14.23
Price-to-Sales (P/S) Ratio
0.27 0.22 0.29 0.29 0.38
Price-to-Book (P/B) Ratio
1.00 0.66 0.81 0.84 1.13
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 2.22 10.13 12.00 8.91
Price-to-Operating Cash Flow Ratio
0.00 2.05 7.44 8.44 6.52
Price-to-Earnings Growth (PEG) Ratio
-1.63 0.23 -1.18 4.43 2.74
Price-to-Fair Value
1.00 0.66 0.81 0.84 1.13
Enterprise Value Multiple
6.11 4.26 5.62 5.36 7.17
Enterprise Value
14.81B 10.65B 12.40B 12.90B 16.73B
EV to EBITDA
5.58 4.26 5.62 5.36 7.17
EV to Sales
0.31 0.27 0.37 0.38 0.53
EV to Free Cash Flow
0.00 2.69 12.92 16.16 12.54
EV to Operating Cash Flow
0.00 2.49 9.48 11.36 9.18
Tangible Book Value Per Share
3.65K 3.45K 2.96K 2.72K 2.26K
Shareholders’ Equity Per Share
3.75K 3.52K 3.21K 3.03K 2.78K
Tax and Other Ratios
Effective Tax Rate
0.40 0.35 0.41 0.41 0.42
Revenue Per Share
12.86K 10.62K 9.02K 8.94K 8.38K
Net Income Per Share
301.12 276.71 202.20 226.92 221.31
Tax Burden
0.60 0.63 0.58 0.58 0.58
Interest Burden
1.00 0.97 0.96 0.96 0.96
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 2.57 1.00 0.77 1.26
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis